Skip to main content
RCEL logo

RCEL · AVITA Medical, Inc. · Executive Compensation

Track RCEL — free
$15.65 -1.06 (-6.34%) At close · Oct 30 Q2 2026 earnings call transcript
Market Cap
$484.01M
Shares
30.93M
Volume · Oct 30 597.05K Avg daily vol (3M) 484.46K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David O’Toole $1,532,265
James Corbett $1,407,715
Nicole Kelsey $957,427
Cary Vance $278,053
Fiscal 2024
Executive Total
James Corbett $3,243,885
David O’Toole $1,777,528
Nicole Kelsey $1,288,190
Cary Vance —
Fiscal 2023
Executive Total
James Corbett $2,068,675
David O’Toole $2,006,826
Donna Shiroma $1,236,104
Fiscal 2022
Executive Total
James Corbett $1,495,584
Michael Holder $925,212
Erin Liberto $906,293
Donna Shiroma $903,915
Michael Perry $804,498
David O’Toole —
Fiscal 2021
Executive Total
Michael Holder $2,702,894
Michael Perry $2,240,389
Kathy McGee $2,149,896
Erin Liberto $677,921
James Corbett —

Executive changes

Person Change Filed
Jan Stern Reed Appointed 2026-05-01
Cary Vance Appointed 2026-05-01
Jan Stern Reed Appointed 2026-05-01
Cary Vance Appointed 2026-05-01
Joe Woody Appointed 2026-01-05
Jan Reed Appointed 2025-10-17
Cary Vance Appointed 2025-10-17
Cary Vance Appointed 2025-08-06
Dr. Michael Tarnoff Appointed 2025-08-06
Cary Vance Appointed 2025-06-05
James Corbett Appointed 2025-06-05
Jan Stern Reed Appointed 2025-06-05
Robert McNamara Appointed 2025-06-05
Jeremy Curnock Cook Appointed 2025-06-05
Professor Suzanne Crowe Appointed 2025-06-05
Lou Panaccio Appointed 2025-06-05
Donna Shiroma Retired 2024-07-01
David O’Toole Appointed 2023-06-16
Erin Liberto Resigned 2023-05-12
Robert McNamara Appointed 2023-03-27
Cary Vance Appointed 2023-03-21
Sean Ekins Appointed 2023-01-20
Kathy McGee Resigned 2023-01-20
Michael Holder Resigned 2023-01-20
James Corbett Appointed 2022-09-30

Leadership

Key facts CIK 1762303 CUSIP 05380C102 13F (30d) 11 filings 11 filers Visit website